Racial Disparities in Colorectal Cancer

Current Problems in Cancer

Volumn 31, Issue 3, 2007, Pages 123-133

  Kauh, John ^a   Brawley, Otis W ^a   Berger, Mitchell ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; COLON CARCINOGENESIS; COLORECTAL CANCER; ETHNICITY; HUMAN; OUTCOMES RESEARCH; RACE DIFFERENCE;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 34249323695     PISSN: 01470272     EISSN: 15356345     Source Type: Journal    
DOI: 10.1016/j.currproblcancer.2007.01.002     Document Type: Article

References (37)

1. Edwards B.K., Brown M.L., Wingo P.A., Howe H.L., Ward E., Ries L.A., et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97 (2005) 1407-1427
2. Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute. Available from: http://seer.cancer.gov/csr/1975-2002.
3. Thomas Jr. C.R., Jarosz R., and Evans N. Racial differences in the anatomical distribution of colon cancer. Arch Surg 127 10 (1992) 1241-1245
4. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
5. Ward E., Jemal A., Cokkinides V., Singh G.K., Cardinez C., Ghafoor A., et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54 (2004) 78-93
6. Satia-Abouta J., Galanko J.A., Potter J.D., Ammerman A., Martin C.F., and Sandler R.S. Associations of total energy and macronutrients with colon cancer risk in African Americans and Whites: results from the North Carolina colon cancer study. Am J Epidemiol 158 (2003) 951-962
7. Satia-Abouta J., Galanko J.A., Martin C.F., Ammerman A., and Sandler R.S. Food groups and colon cancer risk in African-Americans and Caucasians. Int J Cancer 109 (2004) 728-736
8. Butler L.M., Sinha R., Millikan R.C., Martin C.F., Newman B., Gammon M.D., et al. Heterocyclic amines, meat intake, and association with colon cancer in a population-based study. Am J Epidemiol 157 (2003) 434-445
9. Chiu H.M., Lin J.T., Shun C.T., Liang J.T., Lee Y.C., Huang S.P., et al. Association of metabolic syndrome with proximal and synchronous colorectal neoplasm. Clin Gastroenterol Hepatol 5 2 (2007) 221-229
10. Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 31 (2002) 925-943
11. Bruce W.R., Giacca A., and Medline A. Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 9 (2000) 1271-1279
12. Ashktorab H., Smoot D.T., Farzanmehr H., Fidelia-Lambert M., Momen B., Hylind L., et al. Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans. Int J Cancer 116 (2005) 914-919
13. Ashktorab H., Smoot D.T., Carethers J.M., Rahmanian M., Kittles R., Vosganian G., et al. High incidence of microsatellite instability in colorectal cancer from. Clin Cancer Res 9 (2003) 1112-1117
14. Pignone M., Rich M., Teutsch S.M., Berg A.O., and Lohr K.N. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137 (2002) 132-141
15. U.S. Preventive Services Task Force. Colon cancer screening (USPSTF recommendation). J Am Geriatr Soc 48 (2000) 333-335
16. Nelson H.D., Humphrey L.L., Nygren P., Teutsch S.M., and Allan J.D. Postmenopausal hormone replacement therapy: scientific review. J Am Med Assoc 288 (2002) 872-881
17. Sansbury L.B., Millikan R.C., Schroeder J.C., Moorman P.G., North K.E., and Sandler R.S. Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites. Am J Epidemiol 162 (2005) 548-558
18. Weir H.K., Thun M.J., Hankey B.F., Ries L.A., Howe H.L., Wingo P.A., et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 95 (2003) 1276-1299
19. Edwards B.K., Brown M.L., Wingo P.A., Howe H.L., Ward E., Ries L.A., et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97 19 (2005) 1407-1427
20. Hiatt R.A., Klabunde C., Breen N., Swan J., and Ballard-Barbash R. Cancer screening practices from National Health Interview Surveys: past, present, and future. J Natl Cancer Inst 94 (2002) 1837-1846
21. Swan J., Breen N., Coates R.J., Rimer B.K., and Lee N.C. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 97 (2003) 1528-1540
22. Hodgson D.C., Fuchs C.S., and Ayanian J.Z. Impact of patient and provider characteristics on the treatment and. J Natl Cancer Inst 93 (2001) 501-515
23. Bach P.B., Pham H.H., Schrag D., Tate R.C., and Hargraves J.L. Primary care physicians who treat blacks and whites. N Engl J Med 351 (2004) 575-584
24. Dayal H., Polissar L., Yang C.Y., and Dahlberg S. Race, socioeconomic status, and other prognostic factors for survival from colo-rectal cancer. J Chronic Dis 40 (1987) 857-864
25. Mayberry R.M., Coates R.J., Hill H.A., Click L.A., Chen V.W., Austin D.F., et al. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst 87 (1995) 1686-1693
26. Potosky A.L., Harlan L.C., Kaplan R.S., Johnson K.A., and Lynch C.F. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 20 (2002) 1192-1202
27. Dominitz J.A., Samsa G.P., Landsman P., and Provenzale D. Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system. Cancer 82 (1998) 2312-2320
28. Dignam J.J., Ye Y., Colangelo L., Smith R., Mamounas E.P., Wieand H.S., et al. Prognosis after rectal cancer in blacks and whites participating in. J Clin Oncol 21 (2003) 413-420
29. Greene S., Benedetti J., and Crowley J. Clinical Trials in Oncology. Second Edition (2003), Chapman and Hall/CRC, Boca Raton, FL 2
30. Wolmark N., Rockette H., Mamounas E., Jones J., Wieand S., Wickerham D.L., et al. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04. J Clin Oncol 17 (1999) 3553-3559
31. O'Connell M.J., Laurie J.A., Kahn M., Fitzgibbons Jr. R.J., Erlichman C., Shepherd L., et al. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol 16 (1998) 295-300
32. Jessup J.M., Stewart A., Greene F.L., and Minsky B.D. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. J Am Med Assoc 294 (2005) 2703-2711
33. McCollum A.D., Catalano P.J., Haller D.G., Mayer R.J., Macdonald J.S., Benson III A.B., et al. Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. J Natl Cancer Inst 94 (2002) 1160-1167
34. Ball J.K., and Elixhauser A. Treatment differences between blacks and whites with colorectal cancer. Med Care 34 (1996) 970-984
35. Shavers V.L., and Brown M.L. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94 (2002) 334-357
36. Alexander D., Jhala N., Chatla C., Steinhauer J., Funkhouser E., Coffey C.S., et al. High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas. Cancer 103 (2005) 2163-2170
37. Tejeda H.A., Green S.B., Trimble E.L., Ford L., High J.L., Ungerleider R.S., et al. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst 88 (1996) 812-816